Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.99
- Piotroski Score 4.00
- Grade Overweight
- Symbol (FOLD)
- Company Amicus Therapeutics, Inc.
- Price $11.27
- Changes Percentage (0.18%)
- Change $0.02
- Day Low $11.15
- Day High $11.32
- Year High $14.57
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $14.00
- High Stock Price Target $19.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.49
- Trailing P/E Ratio -20.51
- Forward P/E Ratio -20.51
- P/E Growth -20.51
- Net Income $-151,584,000
Income Statement
Quarterly
Annual
Latest News of FOLD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Huawei's tri-foldable phone stirs Chinese pride but $2,800 price tag panned
Huawei's new tri-foldable Mate XT smartphone has sparked nationalistic pride in China, seen as out-innovating Apple despite U.S. sanctions. The phone's $2,800 price tag drew criticism, but fans celebr...
By Yahoo! Finance | 19 hours ago -
Visa aims for 10-fold rise in Pakistani use of digital payments
Visa aims to expand digital payments in Pakistan by partnering with 1Link to streamline remittances and promote digital transactions. The plan includes increasing businesses' acceptance of digital pay...
By Yahoo! Finance | 1 day ago -
Google Pixel 9 Pro Fold Interview: The Duality Of The Foldable
Google introduced the Pixel 9 Pro Fold at the Made By Google event, following the Pixel Fold's debut. The new foldable device aims for top-tier performance and design, reflecting the company's commitm...
By Forbes | 1 day ago
